Skip to the page

Data / Drug companies / Olpha As

Olpha As: 8 products in the FDA NDC directory, labeler code 63818

Olpha As (labeler code 63818) lists 8 products in the FDA National Drug Code Directory. By type: 8 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on June 7, 2021.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
63818
Products in commercial distribution
8
Packages
10
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
June 7, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding675%
Bulk ingredients225%

Products by type

TypeProductsShare
Bulk ingredients8100%

Dosage forms

Dosage formProductsShare
Powder8100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Chlorobutanol hemihydrate63818-0005PowderBulk ingredientsJune 7, 2021
Anagrelide hydrochloride63818-0425PowderBulk ingredients for compoundingJuly 13, 2017
Arbaclofen63818-0002PowderBulk ingredients for compoundingJune 6, 2016
Amantadine hydrochloride63818-0435PowderBulk ingredients for compoundingMay 5, 2016
Rimantadine hydrochloride63818-0434PowderBulk ingredients for compoundingMay 5, 2016
Memantine hydrochloride63818-0004PowderBulk ingredients for compoundingMay 5, 2016
Arbaclofen63818-0001PowderBulk ingredients for compoundingMay 5, 2016
Thalidomide63818-0424PowderBulk ingredientsJune 7, 2010

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.